CN Stock MarketDetailed Quotes

Chengdu Olymvax Biopharmaceuticals Inc (688319)

Watchlist
  • 35.00
  • +0.48+1.39%
Market Closed May 7 15:00 CST
14.20BMarket Cap251.80P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc (688319) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
0.43%192.3M
10.02%246.61M
-11.84%169.67M
-21.81%184.32M
-34.72%191.48M
-38.09%224.16M
-45.05%192.46M
-13.10%235.75M
-1.53%293.32M
34.48%362.07M
Transactional financial assets
-88.50%2.6M
-85.14%2.6M
-38.18%47.6M
-70.67%17.6M
-22.07%22.6M
17,499,900.00%17.5M
--77M
9.09%60M
--29M
-100.00%100
Notes receivable and accounts receivable
27.71%709.2M
15.01%655.97M
25.56%665.08M
24.75%617.27M
17.02%555.34M
16.03%570.35M
7.63%529.7M
0.65%494.8M
4.06%474.55M
-0.03%491.55M
-Notes receivable
-28.18%2.63M
-89.71%404.61K
-87.08%168K
-95.09%160.8K
1,120.69%3.66M
1,210.50%3.93M
--1.3M
3.82%3.28M
-89.19%300K
-42.51%300K
-Accounts receivable
28.08%706.57M
15.74%655.57M
25.84%664.91M
25.55%617.11M
16.32%551.67M
15.30%566.42M
7.37%528.4M
0.63%491.52M
4.63%474.25M
0.02%491.25M
Other receivables (including interest and dividends)
7.80%2.18M
156.79%2.58M
37.82%2.62M
37.76%2.34M
-11.84%2.02M
-8.73%1M
67.48%1.9M
-13.99%1.7M
-51.67%2.29M
-70.97%1.1M
-Other receivable
----
156.79%2.58M
----
37.76%2.34M
----
-8.73%1M
----
-13.99%1.7M
----
-70.97%1.1M
Advance payment
-27.04%4.34M
-27.89%6.57M
22.74%9.38M
15.00%8.96M
-17.85%5.95M
117.37%9.11M
58.95%7.65M
15.98%7.79M
47.55%7.24M
78.70%4.19M
Inventories
-21.95%66.46M
-27.19%62.38M
-23.92%68.8M
-10.94%76.04M
11.06%85.15M
18.81%85.68M
17.80%90.44M
0.37%85.38M
-7.77%76.67M
-8.16%72.12M
Other current assets
1,010.52%21.69M
5,701.36%19.62M
95.79%1.06M
84.58%1.66M
70.31%1.95M
105.14%338.23K
-12.84%541.09K
21.72%900.81K
42.05%1.15M
-48.26%164.88K
Total current assets
15.53%998.76M
9.71%996.33M
7.17%964.22M
2.47%908.2M
-2.23%864.48M
-2.47%908.14M
-2.82%899.69M
-2.86%886.32M
4.33%884.22M
-0.50%931.19M
Non Current assets
Fixed assets
----
9.32%393.02M
----
53.11%366.9M
----
50.24%359.5M
----
1.40%239.64M
----
2.29%239.28M
Constru in process
----
7.10%226.26M
----
-12.58%217.5M
----
16.49%211.27M
----
71.90%248.8M
----
33.85%181.35M
Intangible assets
3.29%16.56M
3.49%16.9M
7.28%17.24M
7.55%17.58M
-3.28%16.03M
-2.92%16.33M
-5.97%16.07M
-5.69%16.35M
-5.02%16.57M
-3.94%16.82M
Development expenditure
23.96%353.65M
23.21%348.56M
35.15%330.92M
19.85%289.37M
42.29%285.29M
52.02%282.89M
69.79%244.85M
72.47%241.44M
56.54%200.5M
53.17%186.1M
Long deferred expense
-35.94%5.04M
-36.24%5.49M
-18.72%5.81M
-14.42%6.84M
-11.13%7.87M
-10.99%8.6M
-15.89%7.15M
-13.78%7.99M
-11.83%8.85M
-10.66%9.67M
Deferred tax assets
36.79%24.91M
36.79%24.91M
61.39%22.72M
29.36%18.21M
29.36%18.21M
29.36%18.21M
47.27%14.07M
47.27%14.07M
34.29%14.07M
47.27%14.07M
Usufruct assets
1,574.77%10.32M
640.07%11.4M
406.40%12.48M
222.93%10.94M
-85.71%615.93K
-70.59%1.54M
-60.00%2.46M
-52.17%3.39M
-46.15%4.31M
-41.38%5.24M
Other non current assets
0.00%218K
-61.09%218K
-63.59%577.47K
-88.74%691.82K
-96.13%218K
-98.06%560.28K
-60.69%1.59M
14.19%6.14M
57.78%5.63M
450.89%28.89M
Total non current assets
12.27%1.02B
14.22%1.03B
21.40%980.75M
19.31%928.03M
28.12%909.55M
31.92%898.9M
39.09%807.89M
36.54%777.81M
27.97%709.91M
25.50%681.42M
Total assets
13.86%2.02B
11.95%2.02B
13.90%1.94B
10.34%1.84B
11.28%1.77B
12.06%1.81B
13.34%1.71B
12.28%1.66B
13.68%1.59B
9.04%1.61B
Liabilities
Current liabilities
Short term loan
56.25%30M
23.97%30M
-17.36%20M
-31.51%20M
-34.25%19.2M
0.00%24.2M
-17.12%24.2M
-50.68%29.2M
-27.00%29.2M
-71.53%24.2M
Notes payable and accounts payable
76.92%141.3M
77.38%153.07M
155.75%116.33M
59.70%86.43M
77.62%79.87M
115.43%86.29M
-4.20%45.49M
46.49%54.12M
-8.86%44.97M
-50.35%40.06M
-Accounts payable
76.92%141.3M
77.38%153.07M
155.75%116.33M
59.70%86.43M
77.62%79.87M
115.43%86.29M
-2.08%45.49M
57.19%54.12M
-0.12%44.97M
-47.21%40.06M
Contract liabilities
-53.53%941.31K
93.09%986.43K
482.30%2.12M
-11.42%622.06K
111.31%2.03M
-85.90%510.85K
-88.88%363.35K
-84.44%702.29K
-83.32%958.57K
-46.03%3.62M
Salaries payable
-52.04%204.5K
6.06%16.12M
-5.26%434.38K
5.13%425.2K
5.13%426.39K
10.05%15.2M
7.46%458.5K
4.22%404.45K
37.00%405.6K
-5.40%13.81M
Taxs payable
78.00%14.7M
-73.51%3.64M
98.62%9.12M
69.80%5.86M
57.71%8.26M
104.06%13.76M
243.10%4.59M
-48.99%3.45M
-52.13%5.24M
-50.66%6.74M
Other payable (including interest and dividends)
28.15%444.82M
25.25%461.17M
23.12%405.67M
17.11%383.48M
12.42%347.11M
3.43%368.2M
7.50%329.49M
1.73%327.45M
5.59%308.77M
13.24%355.99M
-Other payable
----
25.25%461.17M
----
17.11%383.48M
----
3.43%368.2M
----
1.73%327.45M
----
13.24%355.99M
Non current liabilities due within one year
29.14%105.06M
-17.58%72.06M
-0.67%78.7M
-5.17%65.95M
156.71%81.35M
175.86%87.42M
296.55%79.23M
248.10%69.55M
216.90%31.69M
216.90%31.69M
Other current liabilities
-53.53%28.24K
93.09%29.59K
31.10%18.03K
-11.42%18.66K
111.31%60.77K
-85.90%15.33K
-85.96%13.75K
-84.44%21.07K
-83.32%28.76K
-46.03%108.66K
Total current liabilities
36.92%737.06M
23.75%737.07M
30.71%632.39M
16.06%562.78M
27.78%538.3M
25.07%595.59M
18.50%483.83M
7.80%484.91M
3.02%421.26M
-9.33%476.22M
Current liabilities
Estimate liabilities
1,841.78%14.46M
2,433.87%13.48M
1,493.51%11.65M
148.47%1.74M
707.14%744.71K
-56.11%532.18K
208.65%731.31K
--698.86K
--92.26K
1,299.10%1.21M
Deferred tax liabilities
241.42%8.39M
241.42%8.39M
204.06%8.26M
-9.44%2.46M
-9.44%2.46M
-9.44%2.46M
5.99%2.72M
5.99%2.72M
5.99%2.72M
5.99%2.72M
Long term deferred income
15.77%28.95M
17.66%29.16M
10.69%26.35M
-5.12%23.25M
25.36%25M
24.07%24.79M
18.98%23.81M
22.24%24.5M
-0.67%19.94M
-0.67%19.98M
Lease liabilities
441.40%3.56M
1,035.74%7.26M
439.87%8.65M
187.60%7.34M
-81.21%656.85K
-85.56%639.08K
-74.74%1.6M
-59.21%2.55M
-56.64%3.5M
-51.05%4.43M
Total non current liabilities
14.42%351.67M
37.44%382.02M
13.69%344.24M
18.25%339.03M
15.90%307.36M
35.17%277.95M
92.14%302.8M
163.38%286.71M
163.39%265.19M
232.74%205.62M
Total liabilities
28.74%1.09B
28.11%1.12B
24.15%976.63M
16.87%901.81M
23.19%845.66M
28.12%873.54M
39.01%786.63M
38.11%771.62M
34.71%686.45M
16.15%681.84M
Shareholders equity
Paid-in capital
-0.06%405.71M
-0.06%405.71M
0.00%405.93M
-0.06%405.93M
-0.06%405.93M
-0.06%405.93M
-0.06%405.93M
0.00%406.16M
0.22%406.16M
0.22%406.16M
Capital reserve funds
-7.79%560.58M
-7.50%560.58M
-2.55%593.69M
-3.25%593.69M
-0.34%607.91M
0.04%606M
1.42%609.25M
4.03%613.62M
5.27%609.97M
4.27%605.75M
Surplus reserve funds
28.13%18.19M
28.13%18.19M
64.79%14.2M
64.79%14.2M
64.79%14.2M
64.79%14.2M
224.18%8.62M
224.18%8.62M
224.18%8.62M
224.18%8.62M
Retained profit
51.02%-50.44M
19.05%-77.63M
54.78%-48.41M
40.52%-82.7M
15.36%-102.97M
-0.25%-95.89M
-39.09%-107.05M
-76.64%-139.03M
-17.65%-121.65M
10.81%-95.65M
Less:Treasury stock
-42.95%3.17M
-42.95%3.17M
0.16%5.56M
-29.97%5.56M
-30.15%5.56M
-30.15%5.56M
-30.26%5.55M
-0.26%7.94M
--7.96M
--7.96M
Shareholders equity without minority interests
1.23%930.87M
-2.27%903.68M
5.34%959.85M
5.01%925.56M
2.72%919.51M
0.85%924.68M
-1.45%911.2M
-3.35%881.43M
1.26%895.13M
4.00%916.91M
Minority interests
-96.51%309.38K
-96.59%300.98K
-12.92%8.49M
-20.13%8.86M
-29.50%8.86M
-36.34%8.82M
-39.32%9.75M
-3.01%11.09M
44.07%12.56M
35.57%13.86M
Total shareholder equity
0.30%931.18M
-3.16%903.98M
5.15%968.34M
4.69%934.42M
2.28%928.37M
0.29%933.5M
-2.10%920.95M
-3.35%892.52M
1.68%907.69M
4.36%930.77M
Total liabilityies and equity
13.86%2.02B
11.95%2.02B
13.90%1.94B
10.34%1.84B
11.28%1.77B
12.06%1.81B
13.34%1.71B
12.28%1.66B
13.68%1.59B
9.04%1.61B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
--
--
Unqualified opinion
Auditor
--
--
--
--
--
--
--
--
--
Zhongqin Wanxin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds 0.43%192.3M10.02%246.61M-11.84%169.67M-21.81%184.32M-34.72%191.48M-38.09%224.16M-45.05%192.46M-13.10%235.75M-1.53%293.32M34.48%362.07M
Transactional financial assets -88.50%2.6M-85.14%2.6M-38.18%47.6M-70.67%17.6M-22.07%22.6M17,499,900.00%17.5M--77M9.09%60M--29M-100.00%100
Notes receivable and accounts receivable 27.71%709.2M15.01%655.97M25.56%665.08M24.75%617.27M17.02%555.34M16.03%570.35M7.63%529.7M0.65%494.8M4.06%474.55M-0.03%491.55M
-Notes receivable -28.18%2.63M-89.71%404.61K-87.08%168K-95.09%160.8K1,120.69%3.66M1,210.50%3.93M--1.3M3.82%3.28M-89.19%300K-42.51%300K
-Accounts receivable 28.08%706.57M15.74%655.57M25.84%664.91M25.55%617.11M16.32%551.67M15.30%566.42M7.37%528.4M0.63%491.52M4.63%474.25M0.02%491.25M
Other receivables (including interest and dividends) 7.80%2.18M156.79%2.58M37.82%2.62M37.76%2.34M-11.84%2.02M-8.73%1M67.48%1.9M-13.99%1.7M-51.67%2.29M-70.97%1.1M
-Other receivable ----156.79%2.58M----37.76%2.34M-----8.73%1M-----13.99%1.7M-----70.97%1.1M
Advance payment -27.04%4.34M-27.89%6.57M22.74%9.38M15.00%8.96M-17.85%5.95M117.37%9.11M58.95%7.65M15.98%7.79M47.55%7.24M78.70%4.19M
Inventories -21.95%66.46M-27.19%62.38M-23.92%68.8M-10.94%76.04M11.06%85.15M18.81%85.68M17.80%90.44M0.37%85.38M-7.77%76.67M-8.16%72.12M
Other current assets 1,010.52%21.69M5,701.36%19.62M95.79%1.06M84.58%1.66M70.31%1.95M105.14%338.23K-12.84%541.09K21.72%900.81K42.05%1.15M-48.26%164.88K
Total current assets 15.53%998.76M9.71%996.33M7.17%964.22M2.47%908.2M-2.23%864.48M-2.47%908.14M-2.82%899.69M-2.86%886.32M4.33%884.22M-0.50%931.19M
Non Current assets
Fixed assets ----9.32%393.02M----53.11%366.9M----50.24%359.5M----1.40%239.64M----2.29%239.28M
Constru in process ----7.10%226.26M-----12.58%217.5M----16.49%211.27M----71.90%248.8M----33.85%181.35M
Intangible assets 3.29%16.56M3.49%16.9M7.28%17.24M7.55%17.58M-3.28%16.03M-2.92%16.33M-5.97%16.07M-5.69%16.35M-5.02%16.57M-3.94%16.82M
Development expenditure 23.96%353.65M23.21%348.56M35.15%330.92M19.85%289.37M42.29%285.29M52.02%282.89M69.79%244.85M72.47%241.44M56.54%200.5M53.17%186.1M
Long deferred expense -35.94%5.04M-36.24%5.49M-18.72%5.81M-14.42%6.84M-11.13%7.87M-10.99%8.6M-15.89%7.15M-13.78%7.99M-11.83%8.85M-10.66%9.67M
Deferred tax assets 36.79%24.91M36.79%24.91M61.39%22.72M29.36%18.21M29.36%18.21M29.36%18.21M47.27%14.07M47.27%14.07M34.29%14.07M47.27%14.07M
Usufruct assets 1,574.77%10.32M640.07%11.4M406.40%12.48M222.93%10.94M-85.71%615.93K-70.59%1.54M-60.00%2.46M-52.17%3.39M-46.15%4.31M-41.38%5.24M
Other non current assets 0.00%218K-61.09%218K-63.59%577.47K-88.74%691.82K-96.13%218K-98.06%560.28K-60.69%1.59M14.19%6.14M57.78%5.63M450.89%28.89M
Total non current assets 12.27%1.02B14.22%1.03B21.40%980.75M19.31%928.03M28.12%909.55M31.92%898.9M39.09%807.89M36.54%777.81M27.97%709.91M25.50%681.42M
Total assets 13.86%2.02B11.95%2.02B13.90%1.94B10.34%1.84B11.28%1.77B12.06%1.81B13.34%1.71B12.28%1.66B13.68%1.59B9.04%1.61B
Liabilities
Current liabilities
Short term loan 56.25%30M23.97%30M-17.36%20M-31.51%20M-34.25%19.2M0.00%24.2M-17.12%24.2M-50.68%29.2M-27.00%29.2M-71.53%24.2M
Notes payable and accounts payable 76.92%141.3M77.38%153.07M155.75%116.33M59.70%86.43M77.62%79.87M115.43%86.29M-4.20%45.49M46.49%54.12M-8.86%44.97M-50.35%40.06M
-Accounts payable 76.92%141.3M77.38%153.07M155.75%116.33M59.70%86.43M77.62%79.87M115.43%86.29M-2.08%45.49M57.19%54.12M-0.12%44.97M-47.21%40.06M
Contract liabilities -53.53%941.31K93.09%986.43K482.30%2.12M-11.42%622.06K111.31%2.03M-85.90%510.85K-88.88%363.35K-84.44%702.29K-83.32%958.57K-46.03%3.62M
Salaries payable -52.04%204.5K6.06%16.12M-5.26%434.38K5.13%425.2K5.13%426.39K10.05%15.2M7.46%458.5K4.22%404.45K37.00%405.6K-5.40%13.81M
Taxs payable 78.00%14.7M-73.51%3.64M98.62%9.12M69.80%5.86M57.71%8.26M104.06%13.76M243.10%4.59M-48.99%3.45M-52.13%5.24M-50.66%6.74M
Other payable (including interest and dividends) 28.15%444.82M25.25%461.17M23.12%405.67M17.11%383.48M12.42%347.11M3.43%368.2M7.50%329.49M1.73%327.45M5.59%308.77M13.24%355.99M
-Other payable ----25.25%461.17M----17.11%383.48M----3.43%368.2M----1.73%327.45M----13.24%355.99M
Non current liabilities due within one year 29.14%105.06M-17.58%72.06M-0.67%78.7M-5.17%65.95M156.71%81.35M175.86%87.42M296.55%79.23M248.10%69.55M216.90%31.69M216.90%31.69M
Other current liabilities -53.53%28.24K93.09%29.59K31.10%18.03K-11.42%18.66K111.31%60.77K-85.90%15.33K-85.96%13.75K-84.44%21.07K-83.32%28.76K-46.03%108.66K
Total current liabilities 36.92%737.06M23.75%737.07M30.71%632.39M16.06%562.78M27.78%538.3M25.07%595.59M18.50%483.83M7.80%484.91M3.02%421.26M-9.33%476.22M
Current liabilities
Estimate liabilities 1,841.78%14.46M2,433.87%13.48M1,493.51%11.65M148.47%1.74M707.14%744.71K-56.11%532.18K208.65%731.31K--698.86K--92.26K1,299.10%1.21M
Deferred tax liabilities 241.42%8.39M241.42%8.39M204.06%8.26M-9.44%2.46M-9.44%2.46M-9.44%2.46M5.99%2.72M5.99%2.72M5.99%2.72M5.99%2.72M
Long term deferred income 15.77%28.95M17.66%29.16M10.69%26.35M-5.12%23.25M25.36%25M24.07%24.79M18.98%23.81M22.24%24.5M-0.67%19.94M-0.67%19.98M
Lease liabilities 441.40%3.56M1,035.74%7.26M439.87%8.65M187.60%7.34M-81.21%656.85K-85.56%639.08K-74.74%1.6M-59.21%2.55M-56.64%3.5M-51.05%4.43M
Total non current liabilities 14.42%351.67M37.44%382.02M13.69%344.24M18.25%339.03M15.90%307.36M35.17%277.95M92.14%302.8M163.38%286.71M163.39%265.19M232.74%205.62M
Total liabilities 28.74%1.09B28.11%1.12B24.15%976.63M16.87%901.81M23.19%845.66M28.12%873.54M39.01%786.63M38.11%771.62M34.71%686.45M16.15%681.84M
Shareholders equity
Paid-in capital -0.06%405.71M-0.06%405.71M0.00%405.93M-0.06%405.93M-0.06%405.93M-0.06%405.93M-0.06%405.93M0.00%406.16M0.22%406.16M0.22%406.16M
Capital reserve funds -7.79%560.58M-7.50%560.58M-2.55%593.69M-3.25%593.69M-0.34%607.91M0.04%606M1.42%609.25M4.03%613.62M5.27%609.97M4.27%605.75M
Surplus reserve funds 28.13%18.19M28.13%18.19M64.79%14.2M64.79%14.2M64.79%14.2M64.79%14.2M224.18%8.62M224.18%8.62M224.18%8.62M224.18%8.62M
Retained profit 51.02%-50.44M19.05%-77.63M54.78%-48.41M40.52%-82.7M15.36%-102.97M-0.25%-95.89M-39.09%-107.05M-76.64%-139.03M-17.65%-121.65M10.81%-95.65M
Less:Treasury stock -42.95%3.17M-42.95%3.17M0.16%5.56M-29.97%5.56M-30.15%5.56M-30.15%5.56M-30.26%5.55M-0.26%7.94M--7.96M--7.96M
Shareholders equity without minority interests 1.23%930.87M-2.27%903.68M5.34%959.85M5.01%925.56M2.72%919.51M0.85%924.68M-1.45%911.2M-3.35%881.43M1.26%895.13M4.00%916.91M
Minority interests -96.51%309.38K-96.59%300.98K-12.92%8.49M-20.13%8.86M-29.50%8.86M-36.34%8.82M-39.32%9.75M-3.01%11.09M44.07%12.56M35.57%13.86M
Total shareholder equity 0.30%931.18M-3.16%903.98M5.15%968.34M4.69%934.42M2.28%928.37M0.29%933.5M-2.10%920.95M-3.35%892.52M1.68%907.69M4.36%930.77M
Total liabilityies and equity 13.86%2.02B11.95%2.02B13.90%1.94B10.34%1.84B11.28%1.77B12.06%1.81B13.34%1.71B12.28%1.66B13.68%1.59B9.04%1.61B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------------------Unqualified opinion
Auditor ------------------Zhongqin Wanxin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More